Jian Xin Chen
Chief Tech/Sci/R&D Officer at BIOMICS BIOPHARMA LTD
Profile
Jian Xin Chen is currently the Chief Technology Officer & Vice President at Biomics Biotechnologies Co., Ltd.
and the Chief Technology Officer at Biomics Biopharma Ltd.
Prior to his current positions, he worked as a Principal at Arbutus Biopharma Corp.
and Alnylam Pharmaceuticals, Inc. Chen received his undergraduate degree from Wuhan University, his doctorate from the University of British Columbia in 1991, and his graduate degree from the Chinese Academy of Sciences in 1984.
Jian Xin Chen active positions
| Companies | Position | Start |
|---|---|---|
| BIOMICS BIOPHARMA LTD | Chief Tech/Sci/R&D Officer | 2010-12-31 |
Biomics Biotechnologies Co., Ltd.
 Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Chief Tech/Sci/R&D Officer | 2010-12-31 |
Former positions of Jian Xin Chen
| Companies | Position | End |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Jian Xin Chen
| Wuhan University | Undergraduate Degree |
| University of British Columbia | Doctorate Degree |
| Chinese Academy of Sciences | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| BIOMICS BIOPHARMA LTD | Process Industries |
| Private companies | 1 |
|---|---|
Biomics Biotechnologies Co., Ltd.
Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Health Technology |
- Stock Market
- Insiders
- Jian Xin Chen
